Corona Remedies Limited
↗Ahmedabad, India
Corona Remedies Limited is an India-focused, brand-centric pharmaceutical formulation company founded in 2004. The company develops, manufactures, and markets a diversified portfolio of prescription-based medicines across therapeutic areas including women's healthcare, cardiology, diabetology, pain management, and urology.
Headquartered in Ahmedabad, Gujarat, the company has established a strong presence in the Indian Pharmaceutical Market (IPM) through a robust distribution network and a large field force of medical representatives. It operates manufacturing facilities in Gujarat and Himachal Pradesh and is actively expanding its capabilities, including a new state-of-the-art hormone manufacturing facility to support its leadership in women's health.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$142M
Founded:2004
Ownership:public
Status:operating
STOCK
Exchange:NSE|BSE
Ticker:CORONA
Market Cap:₹92.73B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Albert David Ltd (co-marketing agreement)
COMPETITION
Position:Challenger
Competitors:Alkem Laboratories, Mankind Pharma, Merck & Co.
LEADERSHIP
Key Executives:
Nirav Mehta - Managing Director & CEO
Kirtikumar Mehta - Chairman
Scientific Founders:Kirtibhai Mehta, Nirav Mehta, Ankur Mehta
LINKS
Website:coronaremedies.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Corona Remedies Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Corona Remedies Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.